Impact of Proximal Tibial Varus Anatomy on Survivorship After Medial Unicondylar Knee Arthroplasty

医学 单室膝关节置换术 生存曲线 胫骨 全膝关节置换术 外科 射线照相术 骨关节炎 骨科手术 内科学 病理 癌症 替代医学
作者
Robert E. Erlichman,Joanne B. Adams,Keith R. Berend,Adolph V. Lombardi,David A. Crawford
出处
期刊:Journal of Arthroplasty [Elsevier]
卷期号:38 (7): 1251-1256 被引量:7
标识
DOI:10.1016/j.arth.2022.12.043
摘要

Background Precise indications for medial unicondylar knee arthroplasty (UKA) continue to be defined. It is unclear if patients who have proximal tibia vara should be considered candidates for UKA. The purpose of this study was to evaluate the impact of proximal tibial varus alignment on outcomes after UKA. Methods A retrospective review identified 2,416 patients (3,029 knees) who underwent mobile-bearing medial UKA with 2-year minimum follow-up or revision. Preoperative radiographs were evaluated, and medial proximal tibial angle (mPTA) was measured. Patients were grouped into two groups as follows: mPTA <80 degrees and mPTA ≥80 degrees. Analyses were performed on the impact of mPTA on clinical outcomes, all-cause revisions, and tibial failures. Results At a mean follow-up of 5 years (range, 0.5 years to 12.8 years), there was not a statistically significant difference in clinical outcomes nor increased risk for all-cause revision or tibial failure in patients who had an mPTA <80°. Mean mPTA in patients who had tibial failures was 82.5° and not significantly different than those who did not have a tibial failure (82.9°) (P = .289). Tibial failure rate in knees with an mPTA <80° was 2.2% and not significantly different than knees with an mPTA ≥80° at 1.4% (P = .211). The all-cause revision rate in knees with an mPTA <80° was 5.8% and was not significantly different than knees with an mPTA ≥80° at 4.9% (P = .492). Conclusion Patients who have tibia vara are not at increased risk for tibial related or all-cause failure in medial UKA. This data may allow surgeons to increase their indications for medial UKA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Xu_W卜完成签到,获得积分10
1秒前
hh完成签到,获得积分10
1秒前
老迟到的小松鼠完成签到,获得积分10
1秒前
侧耳倾听完成签到,获得积分10
2秒前
黄裳完成签到,获得积分10
2秒前
2秒前
yt完成签到,获得积分10
4秒前
FFFFFFG完成签到,获得积分10
4秒前
qixingbao07126完成签到,获得积分10
4秒前
思茶念酒完成签到 ,获得积分10
4秒前
司马秋凌完成签到,获得积分10
6秒前
调皮友安完成签到 ,获得积分10
6秒前
懵懂的梦秋完成签到,获得积分10
6秒前
无限的含羞草完成签到,获得积分10
7秒前
光亮映波完成签到,获得积分10
8秒前
8秒前
957完成签到 ,获得积分10
8秒前
8秒前
明亮依波完成签到,获得积分10
9秒前
冷傲香寒完成签到,获得积分10
9秒前
文献一搜就出完成签到,获得积分10
9秒前
DrW完成签到,获得积分0
10秒前
淮竹完成签到,获得积分10
11秒前
养头猪饿了吃完成签到,获得积分10
11秒前
蔡从安完成签到,获得积分20
11秒前
别摆发布了新的文献求助10
11秒前
11秒前
skysleeper完成签到,获得积分10
13秒前
Shuey完成签到,获得积分10
14秒前
犹豫代曼完成签到,获得积分10
14秒前
爆米花应助Tempo采纳,获得10
14秒前
是阿龙呀完成签到,获得积分10
15秒前
Leo完成签到,获得积分10
15秒前
虚幻谷波完成签到,获得积分10
17秒前
honestapple完成签到,获得积分10
17秒前
JamesPei应助skysleeper采纳,获得10
17秒前
xiong完成签到,获得积分10
18秒前
ZAY完成签到 ,获得积分10
18秒前
夜行完成签到,获得积分10
18秒前
lezard完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6013415
求助须知:如何正确求助?哪些是违规求助? 7582549
关于积分的说明 16140608
捐赠科研通 5160724
什么是DOI,文献DOI怎么找? 2763435
邀请新用户注册赠送积分活动 1743491
关于科研通互助平台的介绍 1634346